281.66
전일 마감가:
$287.53
열려 있는:
$285
하루 거래량:
1.82M
Relative Volume:
3.01
시가총액:
$16.76B
수익:
$2.91B
순이익/손실:
$622.64M
주가수익비율:
26.88
EPS:
10.48
순현금흐름:
$620.14M
1주 성능:
-7.40%
1개월 성능:
-17.79%
6개월 성능:
-31.93%
1년 성능:
-6.96%
워터스 코퍼레이션 Stock (WAT) Company Profile
명칭
Waters Corp
전화
(508) 478-2000
주소
34 MAPLE ST, MILFORD, MA
WAT을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
WAT
Waters Corp
|
281.66 | 18.10B | 2.91B | 622.64M | 620.14M | 10.48 |
![]()
TMO
Thermo Fisher Scientific Inc
|
404.94 | 160.56B | 42.90B | 6.52B | 6.72B | 17.05 |
![]()
DHR
Danaher Corp
|
188.07 | 141.52B | 23.82B | 3.77B | 4.90B | 5.15 |
![]()
IDXX
Idexx Laboratories Inc
|
520.87 | 42.74B | 3.93B | 894.97M | 837.70M | 10.82 |
![]()
A
Agilent Technologies Inc
|
112.04 | 34.11B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
158.96 | 27.70B | 15.50B | 1.33B | 2.16B | 7.34 |
워터스 코퍼레이션 Stock (WAT) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-03-31 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
2025-03-26 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
2025-02-13 | 업그레이드 | Scotiabank | Sector Perform → Sector Outperform |
2025-02-10 | 업그레이드 | Barclays | Underweight → Equal Weight |
2025-01-10 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
2024-12-23 | 개시 | Scotiabank | Sector Perform |
2024-10-08 | 업그레이드 | Jefferies | Hold → Buy |
2024-08-28 | 개시 | Wells Fargo | Overweight |
2024-08-01 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
2024-06-03 | 재개 | Jefferies | Hold |
2023-11-13 | 다운그레이드 | Barclays | Equal Weight → Underweight |
2023-09-28 | 개시 | Bernstein | Mkt Perform |
2023-07-31 | 다운그레이드 | Barclays | Overweight → Equal Weight |
2023-07-31 | 다운그레이드 | Evercore ISI | Outperform → In-line |
2022-12-14 | 개시 | Deutsche Bank | Hold |
2022-08-25 | 개시 | Credit Suisse | Neutral |
2022-07-20 | 개시 | UBS | Neutral |
2022-05-18 | 개시 | Barclays | Overweight |
2022-05-17 | 업그레이드 | BofA Securities | Underperform → Neutral |
2022-04-25 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
2021-10-15 | 재개 | Cowen | Market Perform |
2021-07-06 | 업그레이드 | Evercore ISI | In-line → Outperform |
2021-01-07 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
2020-12-17 | 업그레이드 | Cleveland Research | Underperform → Buy |
2020-12-16 | 업그레이드 | Citigroup | Sell → Neutral |
2020-12-02 | 개시 | Goldman | Neutral |
2020-11-10 | 개시 | KeyBanc Capital Markets | Sector Weight |
2020-07-28 | 업그레이드 | JP Morgan | Underweight → Neutral |
2020-07-16 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
2020-01-08 | 다운그레이드 | Needham | Hold → Underperform |
2020-01-08 | 개시 | Wells Fargo | Underweight |
2020-01-07 | 개시 | Citigroup | Sell |
2019-11-15 | 개시 | Stifel | Hold |
2019-10-09 | 다운그레이드 | Barclays | Equal Weight → Underweight |
2019-07-16 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
2019-06-12 | 다운그레이드 | Cleveland Research | Neutral → Underperform |
2019-05-30 | 개시 | Wolfe Research | Underperform |
2019-01-24 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
2019-01-03 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
2019-01-03 | 개시 | Needham | Hold |
2018-12-12 | 다운그레이드 | JP Morgan | Neutral → Underweight |
2018-11-30 | 다운그레이드 | Goldman | Neutral → Sell |
2018-10-11 | 업그레이드 | Cleveland Research | Sell → Neutral |
모두보기
워터스 코퍼레이션 주식(WAT)의 최신 뉴스
Inside the deal: Waters CEO Udit Batra defends $17.5B merger with BD unit - The Business Journals
Becton Dickinson Biosciences & Diagnostics Unit to Merge With Waters Corp. in $17.5 Billion Deal - MSN
Waters Corp (WAT) Shares Decline 3.39% Amid Analyst Forecast - AInvest
Waters downgraded at Wells Fargo after Becton, Dickinson deal - MSN
Waters to buy Becton unit in a $17.5 billion deal amid tariff pressures - MSN
Under CEO Udit Batra's Leadership, Waters to Merge with BD Unit in $17.5 Billion Deal to Create Life Sciences Powerhouse - INDIA New England News
What analysts say about Waters Corporation stockMarket-beating performance - jammulinksnews.com
Waters Corp. stock underperforms Friday when compared to competitors - MarketWatch
Enovis, CONMED, Astrana Health, Privia Health, and Waters Corporation Stocks Trade Down, What You Need To Know - Yahoo Finance
Taxation With Representation: Wachtell, Slaughter And May - Law360
Is Waters Corporation a good long term investmentFree Daily Trading Room Entry - jammulinksnews.com
Waters Corporation’s SWOT analysis: stock poised for growth amid biotech boom - Investing.com
Becton to merge unit with Waters in $17.5 billion deal - MSN
Waters Corp Is Taking On Thermo Fisher & Danaher With This $17.5 Billion Becton Dickinson Acquisition! - Smartkarma
What to Expect From Waters Corporation's Next Quarterly Earnings Report - MSN
Waters Corp. stock underperforms Tuesday when compared to competitors - MSN
symbol__ Stock Quote Price and Forecast - CNN
Becton to merge biosciences and diagnostics arm with Waters in $17.5 billion deal - MSN
Waters to merge with Becton's biosciences and diagnostics arm in $17.5 billion deal - MSN
Waters (WAT) Stock Target Price Lowered by Baird Analyst | WAT S - GuruFocus
Waters (WAT) Price Target Reduced by Baird Analyst | WAT Stock N - GuruFocus
Waters Shares Dip After $17.5 Billion Merger Announcement with BD Biosciences Unit - MSN
Waters Corp. Deal for Becton Dickinson Unit a Long-Term Play With Some Risks - MSN
Waters stock downgraded at Wells Fargo on BD deal (WAT:NYSE) - Seeking Alpha
Waters Corporation stock hits 52-week low at 297.03 USD By Investing.com - Investing.com Canada
UBS reiterates Neutral rating on Waters stock, maintains $360 price target - Investing.com Nigeria
UBS reiterates Neutral rating on Waters stock, maintains $360 price target By Investing.com - Investing.com South Africa
Waters deal adds variables to ‘clean’ story, says Jefferies - Yahoo Finance
Waters stock rating reiterated at Hold by Stifel after BDX asset acquisition - Investing.com Nigeria
BD Partners With Waters to Build High-Volume Diagnostics Leader - Yahoo Finance
Street View: Waters’ $17.5 billion merger draws both optimism and caution - TradingView
Waters stock price target lowered to $330 from $375 at BofA Securities - Investing.com Nigeria
An $18 bln health deal faces risks outside the lab - Reuters
Waters stock price target lowered to $330 from $375 at BofA Securities By Investing.com - Investing.com South Africa
Waters Corp. & BD to become life science and diagnostics leader - ROI-NJ
Five things: Waters, lab leases, Legacy FC, classic cars and an ocean view - The Business Journals
Waters Corporation: A Path to Diversification via the Becton Diagnostics Merger - AInvest
Waters: Becoming A Diversified Giant Following The Becton Diagnostics Merger - Seeking Alpha
Waters' $17.5B BD Deal: A Bold Bet on Life Sciences Resilience Amid Tariff Storms - AInvest
Stock Movers: Waters, Autodesk, Palantir - Bloomberg
BD’s biosciences & diagnostics unit in $17.5B merger with Waters - BioWorld MedTech
Waters to buy Becton unit in a $17.5 billion deal amid tariff pressures By Reuters - Investing.com
Waters’ Purchase Of BD Biosciences & Dx Brings Growth Potential Alongside Trade-Offs - insights.citeline.com
Waters to combine with BD's biosciences unit, creating a $40B life science and diagnostics heavyweight - R&D World
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MGRM, WAT, VBTX on Behalf of Shareholders - GlobeNewswire Inc.
Becton Dickinson Finds a Partner for Its Biosciences and Diagnostics Business in Waters - Morningstar
Waters to Merge with BD's Life Science and Diagnostics Business - Morningstar
Milford’s Waters Corp. strikes $17.5 billion deal to merge with BD’s diagnostics unit - The Boston Globe
Waters to buy Becton Dickinson unit in a $17.5 billion deal amid tariff pressures - CNBC
Waters, BD Unite in $17.5B Diagnostics Deal - USA Herald
Waters to buy multinational firm’s bioscience division for $17.5B - Worcester Business Journal
워터스 코퍼레이션 (WAT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):